External beam radiotherapy followed by image-guided adaptive brachytherapy in locally advanced cervical cancer: a multicenter retrospective analysis
La radiologia medica · 2024
DOI: 10.1007/s11547-024-01899-4 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift La radiologia medica, 2024. Verfasst von Sofia Elizabeth Cena und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Brachytherapy, Radiotherapy, Image-Guided. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To evaluate oncological outcomes and toxicities in patients with locally advanced cervical cancer (LACC) treated with concurrent chemoradiotherapy followed by image-guided adaptive brachytherapy at two Italian centres. MATERIAL AND METHODS: A retrospective analysis was conducted on 122 patients with LACC treated between 2010 and 2022. Primary endpoints were local control (LC), pelvic control (PC), and nodal control (NC). Secondary endpoints included disease-free survival (DFS), metastasis-free survival (MFS), overall survival (OS), and late toxicity. Correlations between patient characteristics and oncological outcomes were conducted. RESULTS: Brachytherapy planning was CT and MRI-based in 88 (72.1%) and 34 patients (27.9%), respectively. The mean total dose (EQD2) delivered to high-risk clinical target volume was 82 Gy. Overall treatment time was ≤ 50 days and > 50 days in 48 (39.3%) and 74 patients (60.7%), respectively. At a mean follow up of 101 months, 3 and 5-year LC rates were 87% and 85%, respectively. Five-year PC and NC rates were 77% and 85.1%. Five-year DFS and OS were 61% and 65.4%, respectively, with significant correlations between these outcomes and FIGO stage and nodal status at diagnosis. Gastrointestinal, genitourinary and vaginal adverse effects were the most reported late toxicities and 8 (6.5%) grade 3-5 events were observed. 32 patients (26.2%) had vaginal stenosis and it was significantly related to 3D imaging used for brachytherapy planning. CONCLUSIONS: The study confirmed the efficacy and safety of chemoradiotherapy and IGABT for LACC. Full implementation of MRI treatment planning and interstitial techniques could further enhance personalized treatment and outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
- Radiation Oncology Department, Santa Croce and Carle Hospital, Cuneo, Italy.
- Department of Medical Physics, Santa Croce and Carle Hospital, Cuneo, Italy.
- IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
- Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy. liliana.belgioia@unige.it.
- IRCCS Ospedale Policlinico San Martino, Genoa, Italy. liliana.belgioia@unige.it.
Zitieren
APA
Cena, S. E., Olivero, F., Martini, S., Gianello, L., Boriano, A., Merlotti, A. M., Giannelli, F., Tagliafico, A., Bauckneht, M., & Belgioia, L. (2024). External beam radiotherapy followed by image-guided adaptive brachytherapy in locally advanced cervical cancer: a multicenter retrospective analysis. La radiologia medica. https://doi.org/10.1007/s11547-024-01899-4
Vancouver
Cena SE, Olivero F, Martini S, Gianello L, Boriano A, Merlotti AM, et al. External beam radiotherapy followed by image-guided adaptive brachytherapy in locally advanced cervical cancer: a multicenter retrospective analysis. La radiologia medica. 2024. doi:10.1007/s11547-024-01899-4
BibTeX
@article{Cena2024,
author = {Cena, Sofia Elizabeth and Olivero, Francesco and Martini, Stefania and Gianello, Luca and Boriano, Alberto and Merlotti, Anna Maria and Giannelli, Flavio and Tagliafico, Alberto and Bauckneht, Matteo and Belgioia, Liliana},
title = {External beam radiotherapy followed by image-guided adaptive brachytherapy in locally advanced cervical cancer: a multicenter retrospective analysis},
journal = {La radiologia medica},
year = {2024},
doi = {10.1007/s11547-024-01899-4}
}
EUVIMED